No safety concerns yet in trials of GSK's Ebola vaccine
November 17, 2014 at 05:46 AM EST
LONDON, Nov 17 (Reuters) - Almost 200 people have received GlaxoSmithKline's experimental Ebola vaccine in trials in the United States, Britain, Mali and Switzerland, and the safety data so far are "very satisfactory", scientists said on Monday.
